J. Clement

发表

Atypical presentation of fever as hypersensitivity reaction to oxaliplatin

L. Holle, Gurukripa N. Kowlgi, A. Khurana, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagus

L. Holle, F. Forouhar, J. Clement, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer.

C. Sweeney, J. Clement, 2017, Journal of oncology practice.

Hematospermia and Cloacogenic Transitional Cell Carcinoma: A Twist on Significance and Meaning

John A. Taylor, F. Forouhar, J. Clement, 2016, Case reports in urology.

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Omar H. Butt, Alokkumar Jha, M. Bonnen, 2020, Cancer Cell.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Alokkumar Jha, M. Bonnen, S. Shete, 2020, The Lancet.

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear‐cell renal cell carcinoma receiving vascular endothelial growth factor‐targeted therapy

S. Signoretti, T. Choueiri, M. Atkins, 2010, BJU international.

The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinoma.

D. McDermott, J. Clement, 2009, Clinical genitourinary cancer.

Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice‐based on medical chart review

M. Neary, T. Choueiri, W. Oh, 2010, BJU international.

SATB1 and bladder cancer: Is there a functional link?

John A. Taylor, D. Choudhary, B. Woolbright, 2017, Urologic oncology.

Physician–pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice

L. Holle, J. Clement, S. Puri, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Team Approach: The Treatment of Metastatic Tumors of the Femoral Diaphysis

R. Dowsett, Tessa Balach, Rafael A. Pacheco, 2017, JBJS reviews.

Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer

L. Holle, T. Bunz, J. Clement, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Smoking-induced immune deviation contributes to progression of bladder and other cancers

P. Srivastava, F. Duan, J. Clement, 2015, Oncoimmunology.

Potential role of rituximab in metastatic castrate-resistant prostate cancer

L. Holle, P. Bindal, J. Clement, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prostasol and venous thromboembolism.

G. Bubley, J. Clement, 2008, Urology.

Current Therapeutic Approaches to Renal Cell Carcinoma

L. Holle, J. Clement, A. Namakydoust, 2022 .

Critical analysis of contemporary clinical research in muscle‐invasive and metastatic urothelial cancer

G. Sonpavde, M. Galsky, J. Rosenberg, 2013, Cancer.

Updated efficacy and > 1-y follow up from IMvigor210: Atezolizumab (atezo) in platinum (plat) treated locally advanced/metastatic urothelial carcinoma (mUC).

S. Culine, D. Petrylak, R. Dreicer, 2016 .

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma

Philip S. Yu, Sharon S. Choi, Omar H. Butt, 2023, BMC Cancer.

A case of primary colonic small-cell carcinoma arising in a patient with long-standing ulcerative colitis.

J. Clement, Renée M. Marchioni Beery, T. Devers, 2014, Gastrointestinal cancer research : GCR.